Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaijun Su

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug DiscoveryZhihong Li, Yue Wu, Shuai Zhen, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2022
In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug DiscoveryZhihong Li, Yue Wu, Shuai Zhen, et al.
Journal of Medicinal Chemistry|October 28, 2021
Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal AnemiaYancheng Yu, Fulai Yang, Quanwei Yu, et al.
Journal of Medicinal Chemistry|June 27, 2023
Preferred Conformation-Guided Discovery of Potent and Orally Active HIF Prolyl Hydroxylase 2 Inhibitors for the Treatment of AnemiaYue Wu, Linjian Zhang, Zhuoli Sun, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug DiscoveryZhihong Li, Yue Wu, Shuai Zhen, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2022
In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug DiscoveryZhihong Li, Yue Wu, Shuai Zhen, et al.
Journal of Medicinal Chemistry|October 28, 2021
Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal AnemiaYancheng Yu, Fulai Yang, Quanwei Yu, et al.
Journal of Medicinal Chemistry|June 27, 2023
Preferred Conformation-Guided Discovery of Potent and Orally Active HIF Prolyl Hydroxylase 2 Inhibitors for the Treatment of AnemiaYue Wu, Linjian Zhang, Zhuoli Sun, et al.
Pageof 2